Federal Register notice: FDA determines for patent extension purposes that the regulatory review period for Warner-Lamberts Ibrance (palbociclib) is 3...
Federal Register notice: FDA determines for patent extension purposes that the regulatory review period for Boehringer Ingelheims Jardiance (empaglifl...
Merck ends a Phase 3 study of verubescesat in Alzheimers disease patients.
The National Institute of Allergy and Infectious Diseases says it is studying whether blood levels of procalcitonin can predict whether a lower respir...
FDA warns Bayer Pharma about CGMP inspection violations at its drug manufacturing facility in Leverkusen, Germany.
FDA warns Germanys Curasan AG about Quality System and Medical Device Reporting regulation violations in its production of several dental devices.
Federal Register notice: FDA announces a 3/1 Vaccines and Related Biological Products Advisory Committee meeting.
Federal Register notice: FDA announces a 4/30 public workshop entitled Orthopedic Sensing, Measuring, and Advanced Reporting Technology (SMART) Device...